Freeze-drying powder injection containing red-rooted salvia safflower

Abstract

The red sage-safflower freeze dried powder for injection consists of red sage-safflower extract 15-75 wt% and injection supplementary material 25-85 wt%, and the red sage-safflower extract consists of red sage extract 5-95 wt% and safflower extract 5-95 wt%. The red sage-safflower freeze dried powder for injection has the effects of red sage in improving blood circulation, lowering the blood viscosity and reducing blood fat and the effects of safflower in promoting blood circulation, dredging meridian, dispersing blood clots and relieving pain synthesized, clear ingredients, reasonable recipe, controlled quality and greatly raised stability. It is one ideal medicine for treating cardiac and cerebral vascular diseases.

Description

technical field [0001] The invention relates to a biologically active medicinal powder injection made from salvia miltiorrhiza and safflower extracts. Background technique [0002] The dry roots and rhizomes of Salvia miltiorrhiza Bge., a plant of the Labiatae family, are mainly used to treat blood stasis and relieve pain, promote blood circulation and stimulate menstruation, clear heart and eliminate troubles. The hemodynamics of blood circulation, reducing blood viscosity, lowering blood lipids, etc., so it is a commonly used Chinese herbal medicine among the people. In the past, the Danshen extract was only a fat-soluble component - tanshinone, which failed to fully represent the efficacy of Danshen, especially in promoting blood circulation and removing stasis. Although the Danshen injection made from it has been continuously extracted and removed, there is no index tracking , the loss of active ingredients is more serious. Safflower is the dried flower of Carthamus ti...

AI Technical Summary

Problems solved by technology

Although salvia miltiorrhiza and safflower have a certain therapeutic effect on cardiovascular and cerebrovascular diseases, their comprehensive curative effect is not obvious and needs to be further improved

For example, the Danhong injection developed in the 1980s, due to the constraints of the conditions at that time, had the problem of unclear active ingredients in Danhong injection, especially the active ingredients Danshensu, caffeoyl ester, safflower pigment, etc. Chemically active ingredients that are easily oxidized and hydrolyzed are easily oxidized and hydrolyzed in aqueous solution, thereby affecting the quality of Danhong Injection and the effectiveness and safety of clinical use